Schizophrenia Research
Volume 71, Issue 1 , Pages 155-165 , 1 November 2004

Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores

  • Leslie A. Lenert

      Affiliations

    • Corresponding Author InformationCorresponding author. Health Service Research and Development, MC 111-N1, VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA. Tel.: +1-858-552-4325; fax: +1-858-552-4321.
    • VA San Diego Healthcare System, San Diego, CA, USA
    • Department of Medicine, University of California San Diego, La Jolla, CA, USA
  • ,
  • Ann P. Sturley

      Affiliations

    • Veterans Medical Research Foundation, San Diego, CA, USA
  • ,
  • Mark H. Rapaport

      Affiliations

    • Veterans Medical Research Foundation, San Diego, CA, USA
    • Department of Psychiatry, Cedars-Sinai Medical Center CA, USA
  • ,
  • Shannon Chavez

      Affiliations

    • VA San Diego Healthcare System, San Diego, CA, USA
  • ,
  • Penny E. Mohr

      Affiliations

    • Project Hope, Bethesda, MD, USA
  • ,
  • Marcia Rupnow

      Affiliations

    • Project Hope, Bethesda, MD, USA

Received 29 May 2003 ,Revised 14 October 2003 ,Accepted 29 October 2003.

References 

  1. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 2002;21(2):271–292
  2. Devlin NJ, Hansen P, Kind P, Williams A. Logical inconsistencies in survey respondents' health state valuations—a methodological challenge for estimating social tariffs. Health Econ. 2003;12(7):529–544
  3. Gold M, Patrick D, Torrance G, Fryback D, Hadorn D, Kamlet M, et al. Cost-effectiveness in Health and Medicine. New York: Oxford Univ. Press; 1996;
  4. Lee TT, Ziegler JK, Sommi R, Sugar C, Mahmoud R, Lenert LA. Comparison of preferences for health outcomes in schizophrenia among stakeholder groups. J. Psychiatr. Res. 2000;34(3):201–210
  5. Lenert L, Kaplan RM. Validity and interpretation of preference-based measures of health-related quality of life [see comments]. Med. Care. 2000;38(9 Suppl.):II138, II150
  6. Lenert LA, Sturley AE. Use of the internet to study the utility values of the public. Proc.-AMIA Symp. 2002;440–444
  7. Lenert LA, Treadwell JR. Effects on preferences of violations of procedural invariance [in process citation]. Med. Decis. Mak. 1999;19(4):473–481
  8. Lenert LA, Morss S, Goldstein MK, Bergen MR, Faustman WO, Garber AM. Measurement of the validity of utility elicitations performed by computerized interview. Med. Care. 1997;35(9):915–920
  9. Lenert LA, Cher DJ, Goldstein MK, Bergen MR, Garber A. The effect of search procedures on utility elicitations. Med. Decis. Mak. 1998;18(1):76–83
  10. Lenert LA, Sherbourne CD, Sugar C, Wells KB. Estimation of utilities for the effects of depression from the SF-12. Med. Care. 2000;38(7):763–770
  11. Lenert LA, Ziegler J, Lee T, Sommi R, Mahmoud R. Differences in health values among patients, family members, and providers for outcomes in schizophrenia. Med. Care. 2000;38(10):1011–1021
  12. Lenert LA, Sturley AE, Rupnow M. Toward improved methods for measurement of utility: automated repair of errors in utility elicitations. Med. Decis. Mak. 2003;23(1):1–9
  13. Lin A, Lenert LA, Hlatky MA, McDonald KM, Olshen RA, Hornberger J. Clustering and the design of preference—assessment surveys in healthcare [in process citation]. Health Serv. Res. 1999;34(5 Pt. 1):1033–1045
  14. Mahmoud R, Engelhart L, Ollendorf D, Oster G. The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice. J. Clin. Psychiatry. 1999;60(Suppl. 3):42–47 (discussion 48)
  15. Marder SR, Davis JM, Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials [published erratum appears in J. Clin. Psychiatry 1998 Apr;59(4):200]. J. Clin. Psychiatry. 1997;58(12):538–546
  16. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Arch. Gen. Psychiatry. 2003;60(1):82–91
  17. Mohr PE, Chang M, Claxton E, Corley RR, Feldman JJ, Hargreaves WA, et al. Capturing the Heterogeneity of Schizophrenia Disease States. Schizophrenia Research. 2003;
  18. Nichol MB, Sengupta N, Globe DR. Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med. Decis. Mak. 2001;21(2):105–112
  19. Pyne JM, Sullivan G, Kaplan R, Williams DK. Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia. Med. Care. 2003;41(2):208–217
  20. Revicki DA, Shakespeare A, Kind P. Preferences for schizophrenia-related health states: a comparison of patients, caregivers and psychiatrists. Int. Clin. Psychopharmacol. 1996;11(2):101–108
  21. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med. Decis. Mak. 1998;18(2 Suppl.):S68–S80
  22. Sugar CA, Sturm R, Lee TT, Sherbourne CD, Olshen RA, Wells KB, et al. Empirically defined health states for depression from the SF-12. Health Serv. Res. 1998;33(4 Pt. 1):911–928
  23. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med. Care. 2000;38(6):583–637
  24. United States. National Telecommunications and Information Administration . Falling Through the Net [IV]: Toward Digital Inclusion. Washington, DC: U.S. Dept. of Commerce National Telecommunications and Information Administration; 2000;
  25. White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS study group. Psychopathology. 1997;30(5):263–274

PII: S0920-9964(03)00348-7

doi: 10.1016/j.schres.2003.10.010

Schizophrenia Research
Volume 71, Issue 1 , Pages 155-165 , 1 November 2004